CVS · CVS HEALTH Corp
$97.16
+2.17 (+2.28%)
At close · Aug 14
Market Cap
$124.26B
Shares
1.28B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-05-18 | 2026-05-14 | |
| 8-K | 2026-05-06 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| DEF 14A | 2026-04-03 | 2026-05-14 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-19 | 2026-03-18 | |
| 10-K | 2026-02-10 | 2025-12-31 | |
| 8-K | 2026-02-10 | — | |
| 8-K | 2025-12-09 | — | |
| 8-K | 2025-11-20 | — | |
| 8-K | 2025-10-29 | — | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2025-09-22 | — | |
| 8-K | 2025-08-15 | 2025-08-11 | |
| 8-K | 2025-07-31 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-05-20 | 2025-05-15 | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-05-01 | — | |
| 8-K | 2025-04-08 | 2025-04-07 | |
| DEF 14A | 2025-04-04 | 2025-05-15 | |
| 10-K | 2025-02-12 | 2024-12-31 | |
| 8-K | 2025-02-12 | — | |
| 8-K | 2024-12-17 | 2024-12-16 | |
| 8-K | 2024-12-10 | — | |
| 8-K | 2024-12-09 | — | |
| 8-K | 2024-12-06 | — | |
| 8-K | 2024-12-05 | 2024-12-03 | |
| 8-K | 2024-12-02 | — | |
| 8-K | 2024-11-18 | 2024-11-12 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-11-06 | — | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-10-18 | 2024-10-17 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-05-22 | 2024-05-16 | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-05-08 | 2024-05-07 | |
| 10-Q | 2024-05-01 | 2024-03-31 | |
| 8-K | 2024-05-01 | — | |
| DEF 14A | 2024-04-05 | 2024-05-16 | |
| 8-K | 2024-03-05 | — | |
| 8-K | 2024-02-07 | — | |
| 10-K | 2024-02-07 | 2023-12-31 | |
| 8-K | 2024-01-05 | — | |
| 8-K | 2023-12-05 | — | |
| 10-Q | 2023-11-01 | 2023-09-30 |
Showing 1–50 of 151 filings
Key facts
CIK
64803
CUSIP
126650100
13F (30d)
1803 filings
1737 filers
Visit website
Investor relations